Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michelle L. Cook Sangar"'
Autor:
James M. Olson, Brandon J. Wainwright, Amanda Millar, Pengxiang Ji, Sue E. Knobluagh, Melissa J. Davis, Madison W. Nakamoto, Laura A. Genovesi, Michelle L. Cook Sangar
Figure S1 shows the delineation of the tumor in MRI images.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6346d0513681bcd73e07e2c2e1e8edcb
https://doi.org/10.1158/1078-0432.22467318
https://doi.org/10.1158/1078-0432.22467318
Autor:
James M. Olson, Brandon J. Wainwright, Amanda Millar, Pengxiang Ji, Sue E. Knobluagh, Melissa J. Davis, Madison W. Nakamoto, Laura A. Genovesi, Michelle L. Cook Sangar
Purpose: Bioinformatics analysis followed by in vivo studies in patient-derived xenograft (PDX) models were used to identify and validate CDK 4/6 inhibition as an effective therapeutic strategy for medulloblastoma, particularly group 3 MYC-amplified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11164dc7c70b6b66f2eed09944c3c7bb
https://doi.org/10.1158/1078-0432.c.6526611
https://doi.org/10.1158/1078-0432.c.6526611
Autor:
Mesfin M. Gewe, Fiona Pakiam, Natalie Nairn, Kelly Byrnes-Blake, Mi-Youn Brusniak, Dennis M. Miller, Christopher Mehlin, James M. Olson, Andrew D. Strand, Chunfeng Yin, Colin Correnti, Elizabeth Nguyen, Raymond O. Ruff, Julian A. Simon, Roland K. Strong, Emily J. Girard, Gene Hopping, Michelle L. Cook Sangar, Andrew J. Mhyre
Publikováno v:
Science Translational Medicine. 12
On-target, off-tissue toxicity limits the systemic use of drugs that would otherwise reduce symptoms or reverse the damage of arthritic diseases, leaving millions of patients in pain and with limited physical mobility. We identified cystine-dense pep
Autor:
Madison W. Nakamoto, Pengxiang Ji, Brandon J. Wainwright, Sue E. Knobluagh, Michelle L. Cook Sangar, Melissa J. Davis, Amanda Millar, James M. Olson, Laura A. Genovesi
Publikováno v:
Clinical Cancer Research. 23:5802-5813
Purpose: Bioinformatics analysis followed by in vivo studies in patient-derived xenograft (PDX) models were used to identify and validate CDK 4/6 inhibition as an effective therapeutic strategy for medulloblastoma, particularly group 3 MYC-amplified
Autor:
Cook Sangar, Michelle L., Girard, Emily J., Hopping, Gene, Yin, Chunfeng, Pakiam, Fiona, Brusniak, Mi-Youn, Nguyen, Elizabeth, Ruff, Raymond, Gewe, Mesfin M., Byrnes-Blake, Kelly, Nairn, Natalie W., Miller, Dennis M., Mehlin, Christopher, Strand, Andrew D., Mhyre, Andrew J., Correnti, Colin E., Strong, Roland K., Simon, Julian A., Olson, James M.
Publikováno v:
Science Translational Medicine; 3/4/2020, Vol. 12 Issue 533, p1-12, 12p